The effectiveness of coordinated care for people with chronic respiratory disease by Smith, B. et al.
 PUBLISHED VERSION  
 
 
Smith, Brian James; Mc Elroy, Heather Joy; Ruffin, Richard Ernest; Frith, Peter A.; Heard, 
Adrian R.; Battersby, Malcolm W.; Esterman, Adrian Jeffrey; Del Fante, Peter; McDonald, 
Peter J.  
The effectiveness of coordinated care for people with chronic respiratory disease Medical 
Journal of Australia, 2002; 177(9):481-485 
 
























This document has been archived with permission from the editor of the Medical 




MJA Vol 177 4 November 2002 481
RESEARCH
The Medical Journal of Australia ISSN: 0025-729X 4 November 2002 177 9 481-
485
©The Medical Journal of Australia 2002 www.mja.com.au
Research
IN THE LATE 1990S, nine coordinated
care trials took place across Australia.
Their overall aim was to test whether
multidisciplinary care planning and serv-
ice coordination improved health and
wellbeing for people with chronic health
conditions or complex care needs within
existing resources.1 A recent review of
studies of outreach nursing, which has
features in common with coordinated
care, found increased costs and no
reduction in hospitalisation, but slight
improvements in quality of life.2
In the South Australian trial, Health-
Plus,3 one of eight components was the
Western Respiratory Project. Its aims
included:
■ sharing of care between hospital-
based specialists, general practitioners,
and other community-based healthcare
practitioners (including domiciliary care,
Royal District Nursing Service) in a
community-based approach, with GPs
central to the planning and monitoring
of prospective care;
■ pooling of federal and state health
funds to provide efficient healthcare
service delivery and enhance patient care
with similar or reduced overall healthcare
system costs; and
■ producing evidence on the change in
health outcomes as a result of the




Recruitment began in July 1997 and
continued until September 1998. Fol-
low-up ended in December 1999.
Patients were recruited from the western
(intervention group) and northern (com-
parison group) suburbs of Adelaide, in
collaboration with the Adelaide western
and northern Divisions of General Prac-
tice. The geographical comparison
region was selected pre-hoc on the basis
of previous surveys4 as the region of
Adelaide that best matches the socio-
demographic features of the western
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ABSTRACT
Objectives:  To evaluate the effectiveness of coordinated care for chronic 
respiratory disease.
Design and setting:  Community-based geographical control study, in western 
(intervention) and northern (comparison) metropolitan Adelaide (SA).
Participants:  377 adults (223 intervention; 154 comparison) with chronic 
obstructive pulmonary disease, asthma or other chronic respiratory condition, 
July 1997 to December 1999.
Intervention:  Coordinated care (includes care coordinator, care guidelines, 
service coordinator and care mentor).
Main outcome measures: Hospital admissions (any, unplanned and respiratory), 
functionality (activities of daily living) and quality of life (SF-36 and Dartmouth 
COOP).
Results:  At entry to the study, intervention and comparison subjects were 
dissimilar. The intervention group was 10 years older (P < 0.001), less likely to 
smoke (P = 0.014), had higher rates of hospitalisation in the previous 12 months 
(P < 0.001) and had worse self-reported quality of life (SF-36 physical component 
summary score [P < 0.001] and four of nine COOP domains [P = 0.002–0.013]). 
After adjustment for relevant baseline characteristics, coordinated care was not 
associated with any difference in hospitalisation, but was associated with some 
improvements in quality of life (SF-36 mental component summary score 
[P = 0.023] and three of nine COOP domains [P = 0.008–0.031]) compared with the 
comparison group.
Conclusions:  Coordinated care given to patients with chronic respiratory disease 
did not affect hospitalisation, but it was associated with an improvement in some 
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quality-of-life measures.
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region. The number of GPs per 1000
patients (northern, 1.21; western, 1.34)
is also similar for the two regions. Partic-
ipating GPs recruited patients opportun-
istically, so details of the eligible
population were not collected.
This study should be considered as a
form of “action research”, where a cycle
of action and critical review led to
improved GP participation and refine-
ment of the methodology throughout the
study.5,6
Ethics approval was obtained by the
Ethics of Human Research Committee
at the North Western Adelaide Health
Service and clearance to obtain data was
received from the Health Insurance
Commission.
Selection criteria
Participants had to be at least 18 years
old, have a chronic respiratory illness,
and have complex care needs. Initially,
extra criteria were used, including hospi-
talisation within the past 12 months.
However, as part of the action research
methodology, these criteria were dropped
to ensure adequate recruitment. Selec-
tion criteria were applied by participating
GPs on a patient self-report basis, and
were checked by the service coordinators.
The coordinated care intervention
GPs took the role of “care coordinators”
and supervised the multidisciplinary
management of each patient.7 To facili-
tate this process, multidisciplinary care
plan generators (CPGs) were con-
structed with input from consumers
(patients and their carers), GPs, respira-
tory physicians, allied health profession-
als, the Royal District Nursing Service,
domiciliary care and an epidemiologist.
Relevant published medical evidence
and the published guidelines of the tho-
racic societies of Australia and New Zea-
land, Britain and America8-10 were
incorporated. The CPGs included a rec-
ommended annual number of GP visits,
respiratory function tests, other diagnos-
tic tests and physician visits where neces-
sary.
GPs received and were reimbursed for
two to four hours of orientation.
GPs were supported by “service coor-
dinators” (nurses), who liaised with the
patient, GP, respiratory specialist and
other healthcare professionals, moni-
tored the patient, and encouraged imple-
mentation of the evolving care plan.
Duties included booking investigations,
arranging case conferences, referrals,
home visits and collecting data for evalu-
ation of the intervention.
Outcome measures
Quality of life and functionality
Quality of life was measured by the SF-
3611 and the Dartmouth COOP func-
tion charts (COOP).12,13 Using the SF-
36 as an outcome measure was a require-
ment of the coordinated care trials, and
the physical and mental component
summary scores were selected pre-hoc as
those most relevant to our study.
Functionality was measured by part of
the COOP function charts, the Older
Americans Resources and Services inde-
pendent activities of daily living ques-
tionnaire (OARS),14 and the Modified
Barthel Index (MBI).15 The COOP was
chosen as a simple, graphic question-
naire suitable for frail, elderly people
with respiratory disease, including those
with limited English.
All questionnaires were administered
at baseline and on study termination in
December 1999, after at least 12
months’ study participation. The SF-36
was administered by telephone. Where
telephone contact could not be made
because of lack of telephone or insuffi-
cient English, the interview was con-
ducted by the service coordinator with
the assistance of a family member where
necessary. All the other questionnaires
were administered by service coordina-
tors. Interviewers were not blinded to the
study hypotheses.
Health service utilisation
Information about hospital admissions
for the study period and the previous 12
months was collected for all patients
from South Australian Department of
Human Services hospital separation data
to enable an intention-to-treat analysis.
Patients can be identified across hospi-
tals and admissions in more than 90% of
cases through Medicare numbers.
Unplanned admissions were coded as a
separate field in this data source, and
respiratory admissions were identified by
Australian National Diagnosis Related
Groups16 176 (pulmonary oedoma and
respiratory failure) or 177 (chronic
obstructive airways disease).
Medical Benefits Scheme (MBS),
Pharmaceutical Benefits Scheme (PBS)
and Department of Veterans’ Affairs
(DVA) data were obtained from the
Health Insurance Commission (HIC).17
Each participant received an explanation
of the rationale for collecting these data,
and, if agreeable, filled out a consent
form for data release. Information
regarding deaths was obtained from the
SA Death Register through the Depart-
ment of Human Services.
Statistical methods
Cox proportional hazards regressions
(adjusted for age and previous hospitali-
sation) were used to check for differ-
ences in the length of time in the trial
between groups, and to check for differ-
ences in time until death between
groups.
For the baseline demographic and
prior health service utilisation data and
the baseline quality-of-life characteris-
tics, unadjusted comparisons between
groups were performed using 2 test, t
test or Wilcoxon rank-sum test, as
applicable. Changes in SF-36 compo-
nent summary scores were compared
between groups using multiple linear
regression on a subset of participants
who completed both SF-36 question-
naires, adjusting for five potential con-
founders (MBS expenditure and
hospitalisation in the 12 months before
the study, age, sex, and smoking).
Improvements in functionality were
assessed by counting the number of
people in each group considered better,
the same or worse than baseline at the
end of the study, with adjustment for
potential confounders (the same five as
for the SF-36 analysis) using a multiple
ordered logit model.15
For both the SF-36 and improve-
ments-in-functionality analysis, only
people who completed baseline and fol-
low-up questionnaires were included.
Consequently, adjustment for length of
time in the study was not required.
Differences in hospitalisation for any
reason, respiratory admission and
unplanned admission were examined
using multiple logistic regression, adjust-
ing for the same five confounders. Analy-
sis was on an intention-to-treat basis.
Length of time in the study was not a
significant predictor and so was omitted.
Average length of stay was analysed using
a t test, including only those patients who
had been hospitalised.
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All analyses were completed using
STATA statistical software.18
The national evaluators of the coordi-
nated care trials performed power cal-
culations on a trial-wide basis based on
potential changes to SF-36 scores. For
our study, power calculations19 were
performed for both quality of life and
hospitalisation. For a change of 10
points on the 100-point scale of the SF-
36 component summary scores (SD,
10; power, 90%;  = 0.05, using a two-
sided t test and an intervention : control
ratio of 2:1) a sample size of 51 (34
intervention; 17 control) would be
required. For a 50% reduction in the
incidence of hospitalisation over a 12-
month period from a baseline of 42%
(power, 90%;  = 0.05, using a 2 test
for an intervention : control ratio of 2:1)
the sample size required would be 245
(163 intervention; 82 control).
Health costs
Costs associated with healthcare service
utilisation (MBS and PBS services, inpa-
tient private and public hospital use, dom-
iciliary care, and district nursing) and
coordinated care are reported as costs per
patient-year. Patient contribution to the
cost of services was not included, and cost
data from the DVA and hospital outpa-
tients were not available. Data were recal-
ibrated to allow for historical difference
between groups during the two financial
years 1995 to 1997. Financial data for the
two years were obtained for all study
participants and used to standardise inter-
vention and control subjects at baseline.
This standardisation produced an individ-
ual recalibration factor for each type of
service. Also, in adjusting for historical
costs, it allowed for pre-baseline differ-
ences such as patient age. Inpatient costs
were estimated using the casemix cost-
weighting system, with outliers included
at full cost. The casemix costs were veri-




The Western Respiratory Project
involved 223 intervention patients, 154
comparison patients, 92 care coordinator
GPs, and six service coordinators (Box
1). The difference in follow-up time was
not significant (hazard ratio, 0.89; 95%
CI, 0.64–1.25). Thirty patients had less
than 90 days’ follow-up (intervention,
25; comparison, 5) due to an adjustment
being made to the study start date after
recruitment (these patients were not
included in the analysis). The interven-
tion period varied between patients
because of an extended recruitment
period with an associated shortening of
the period available for the intervention.
One hundred and eighty-two subjects
did not complete the study (Box 1). The
difference in death rates between the
groups was not significant (hazard ratio,
0.62; 95% CI, 0.29–1.28) when adjusted
for age and previous hospital admissions.
Baseline characteristics
At entry to the study, the median age of
the intervention group was 10 years
older than the geographic comparison
group (P < 0.001). The intervention
group had a lower proportion of women
(45%, compared with 62% in the com-
parison group), were less likely to smoke
(P = 0.014), less likely to speak English
at home (P < 0.001), and had higher
rates of hospitalisation in the previous 12
months (P < 0.001). In addition, the
intervention group had worse SF-36
physical component summary scores
(P < 0.001).
About 90% of participants completed
each quality-of-life questionnaire at the
beginning of the study (Box 1). The
lowest response rate of 71% was attained
in the intervention group for the SF-36.
These non-respondents were more likely
to withdraw from the study, less likely to
have had eight GP visits in the previous
12 months, and more likely to have been
born outside Australia and not to speak
English at home. Similar characteristics
were demonstrated by non-respondents
for each of the questionnaires.
The baseline COOP function charts
indicated that the intervention group
were more likely to report diminished
functioning (physical condition, breath-
lessness) and a poorer perception of their
overall health and quality of life. Half the
intervention group required assistance in
at least one task of daily living measured
by OARS. There was no overall differ-
ence between intervention and compari-
son groups in activities of daily living
measured by the MBI.
Health services utilisation
For patients receiving coordinated care
there was no difference in the odds of
hospitalisation (odds ratio [OR], 1.13;
1: Flow diagram of participation in the study by the intervention and 
comparison groups
Intervention group




SF-36 n = 158 (71%)
COOP n = 181 (81%)
OARS n = 204 (91%)




Residential care 1 (died after leaving trial)




Residential care 1 (died after leaving trial)
Other 36 (2 died after leaving trial)
Comparison group




SF-36 n = 137 (89%)
COOP n = 143 (93%)
OARS n = 146 (95%)
MBI n = 140 (91%)
114 (51%) remained in
trial until 31/12/1999
Median follow-up 533 days
(range 92-813)
Number completing:
SF-36 n = 83 (73%)
COOP n = 95 (83%)
OARS n = 89 (78%)
MBI n = 88 (77%)
81 (53%) remained in
trial until 31/12/1999
Median follow-up 633 days
(range 101-793)
Number completing:
SF-36 n = 67 (83%)
COOP n = 65 (80%)
OARS n = 61 (75%)
MBI n = 59 (73%)
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95% CI, 0.72–1.75), respiratory hospi-
talisations (OR, 0.71; 95% CI, 0.40–
1.28) or unplanned hospitalisations
(OR, 0.78; 95% CI, 0.47–1.30) after
adjusting for baseline characteristic dif-
ferences. Length of stay did not differ
between the two groups.
Functionality and quality of life
Changes in quality of life and functional-
ity scores are summarised in Box 2.
Multivariate analysis showed no signifi-
cant difference in change in SF-36 phys-
ical component score. The overall
mental component score improved with
coordinated care.
The intervention group experienced
less deterioration in two out of three
symptom-related COOP items (emo-
tional condition and pain) and an
improvement in COOP perceived quality
of life. There was no difference between
the groups in respect to functional
COOP or OARS items.
Healthcare costs
On average, a person receiving coordi-
nated care in the Western Respiratory
Study incurred $8312 per year, includ-
ing an initial $40 enrolment cost, com-
pared with an average of $6882 per year
for a person receiving usual care (Box 3).
Modifying cost outliers to two standard
deviations from the mean did not lead to
any significant change in the results for
healthcare costs compared with includ-
ing outliers at full cost. This demon-
strates that outliers had little impact.
DISCUSSION
1.Discussion
We studied the effects of coordinated
care in people with chronic and complex
respiratory disease, and found a reduced
deterioration in mental aspects of quality
of life, symptoms of pain and emotional
condition, but no difference in physical
aspects or functional measures. We
found no cost saving to the healthcare
system and no reduction in hospital
admissions.
Key limitations of the study include the
lack of a study sampling frame. Non-
participants are not recorded and caution
must be taken in generalising the results.
Further, our geographical comparison
group was not as similar to the interven-
tion group as intended, requiring many
adjustments in the analyses for confound-
ers such as age and previous hospitalisa-
tion. The higher prevalence of older men,
who were less likely to speak English at
home, suggested that some GPs in the
intervention region had patients of a con-
siderably different demographic back-
ground to subjects recruited by GPs in
the comparison region. This study design,
and the extent of associated adjustments,
may have weakened the validity of the
differences in outcomes.
The action research approach and lack
of interviewer blinding may have limited
scientific rigour. Although this project
was a compromise between scientific
2: Percentage of patients who showed improvement or deterioration in functionality and quality of life*
Control (C) (usual care) Intervention (I) (coordinated care)
P†Deteriorated Same Improved Deteriorated Same Improved
SF-36 physical (n = 150; C, 67; I, 83) 15% 73% 12% 13% 72% 15% 0.627
SF-36 mental (n = 150; C, 67; I, 83) 24% 66% 10% 16% 59% 25% 0.023
MBI (n = 147; C, 59; I, 88) 7% 80% 13% 23% 68% 9% 0.080
OARS (n = 150; C, 61; I, 89) 25% 52% 23% 28% 42% 30% 0.226
COOP
Physical condition (n = 159; C, 65; I, 94) 29% 48% 23% 21% 63% 16% 0.528
Daily activities (n = 160; C, 65; I, 95) 28% 46% 26% 31% 46% 23% 0.785
Social activities (n = 159; C, 65; I, 94) 37% 43% 20% 32% 46% 22% 0.162
Emotional (n = 160; C, 65; I, 95) 46% 31% 23% 24% 51% 25% 0.008
Breathlessness (n = 158; C, 65; I, 93) 29% 52% 19% 25% 54% 22% 0.162
Pain (n = 160; C, 65; I, 95) 43% 29% 28% 21% 54% 25% 0.031
Overall condition (n = 160; C, 65; I, 95) 37% 35% 28% 19% 51% 31% 0.072
Quality of life (n = 160; C, 65; I, 95) 31% 49% 20% 21% 49% 29% 0.030
Social support (n = 160; C, 65; I, 95) 22% 60% 18% 11% 68% 21% 0.076
*Improvement or deterioration means a change in SF-36 score of 12 or more, and a change of one unit on the five-item COOP and MBI scales and on the 15-item OARS 
scale. †Except for the SF-36 comparisons, P values are adjusted for MBS expenditure in the previous 12 months, age, sex, smoking and hospitalisation in the previous 
12 months.
3: Recalibrated costs per patient-year for coordinated care and 
usual care
Usual care Coordinated care Difference Recalibration factor
MBS $980 $1111 $131 1.003
PBS $909 $1038 $129 1.254
Hospital inpatient $4856 $5035 $179 2.079
Other $137 $257 $120 1.355
Enrolment $0 $40 $40
Care planning $0 $182 $182
Coordination $0 $649 $649
Total $6882 $8312 $1430
Data not available for Department of Veterans’ Affairs and hospital (non-inpatient) costs. 
MBS=Medical Benefits Scheme. PBS=Pharmaceutical Benefits Scheme. 
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evaluation and action research, it pro-
vided an important, large scale, commu-
nity-based and shared healthcare
provider intervention. Out of necessity,
the design was flexible to adapt to the
requests of multiple stakeholders, partic-
ularly GPs and their patients, for the
duration of the study. Without such flex-
ibility, implementation across two broad
geographical regions would have been
impractical, and it is doubtful that GPs
would have agreed to initiate or maintain
involvement in the study.
Although the study had sufficient
power to show differences in admissions
and quality of life, we found no reduc-
tion in admissions, and only modest pos-
itive benefit with respect to quality of life.
This might be primarily due to further
limitations of the study. Firstly, factors
such as the variation in the period of the
intervention and the high dropout rate
reduced the potential for demonstrating
an effect. Such factors are not unex-
pected in studies of elderly, chronically ill
subjects in community settings. Sec-
ondly, owing to patient de-identification
in the study database, we were unable to
link patients and GPs in the comparison
group. This meant that we were unable
to adjust for clustering by GP in the
analysis. However, as most GPs had only
1–3 patients (intervention 223 patients,
92 GPs; comparison 154 patients, 70
GPs), the clustering effects are expected
to be minor.
The increased dropout rate immedi-
ately after 12 months in the intervention
group appears to have resulted from dis-
satisfaction with the interview question-
naire. This is an important consideration
when lengthy quality-of-life and other
measures are being asked of often frail,
elderly, chronically ill participants.21
Our results suggest that a general prac-
tice-based intervention such as coordi-
nated care may be the wrong approach
for people with chronic respiratory dis-
ease. Many patients with advanced respi-
ratory disease may be so ill that
coordinated care can have little effect on
the course of the illness, the patient’s well
being, or healthcare service utilisation. It
is difficult for large community studies
such as the coordinated care trials to
target specific subgroups of the popula-
tion with chronic respiratory disease
owing to the large participant numbers
that such studies require. It may be
better in future to focus on locally tar-
geted programs, such as pulmonary
rehabilitation. Pulmonary rehabilitation
has demonstrated benefits in chronic
obstructive pulmonary disease,22 and a
home-based program could be incorpo-
rated with home-based management to
improve future coordinated care inter-
ventions for respiratory disease.
A Cochrane review of a large, well-
designed outreach nursing care study for
patients with chronic obstructive pulmo-
nary disease2 also showed only modest
improvements in quality of life, accom-
panied by a substantial increase in
healthcare system costs.23 Congruent
findings have been demonstrated in a
locally conducted outreach respiratory
nurse program, and by a systematic
review of 15 studies of preventive home
care visits in elderly patients.24 The value
of modest increases in quality of life in
people with complex and chronic condi-
tions, for substantial increase in health-
care costs, needs to be considered at a
societal level. Given the many difficulties
reported with coordinated care in this
study and the lack of cost benefits, the
future of wide-ranging coordinated care
interventions looks limited. Since the
introduction in 2001 of the Enhanced
Primary Care items to the MBS (for
health assessments, care plans and case
conferences), it is unclear whether the
revised costs of coordinated care will still
outweigh any demonstrated benefits, but
the problems encountered in this study
are likely to hinder future attempts to
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